Virtus Investment Advisers, Inc. Supernus Pharmaceuticals, Inc. Transaction History
Virtus Investment Advisers, Inc.
- $112 Million
- Q2 2024
A detailed history of Virtus Investment Advisers, Inc. transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Virtus Investment Advisers, Inc. holds 29,148 shares of SUPN stock, worth $1.02 Million. This represents 0.7% of its overall portfolio holdings.
Number of Shares
29,148
Previous 29,148
-0.0%
Holding current value
$1.02 Million
Previous $994,000
21.63%
% of portfolio
0.7%
Previous 0.75%
Shares
2 transactions
Others Institutions Holding SUPN
# of Institutions
260Shares Held
59.3MCall Options Held
47.9KPut Options Held
13.1K-
Black Rock Inc. New York, NY10.4MShares$362 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.14MShares$214 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.27MShares$184 Million1.83% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.87MShares$100 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C32.68MShares$93.4 Million0.08% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $1.87B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...